Cresco Labs Posts $162M Q4 Revenue, Boosts Margins Sequentially
Summary
Cresco Labs announced its Q4 2025 financial results, reporting $162 million in revenue and demonstrating sequential margin improvement. The company also generated $40 million in Adjusted EBITDA and $27 million in operating cash flow for the quarter. For the full year 2025, revenue reached $656 million, with $73 million in operating cash flow and $38 million in free cash flow. While the company reported a net loss of $89 million for the quarter, this included $93 million in one-time, non-cash charges. These results provide a crucial update on Cresco Labs' operational performance and financial stability, with the sequential margin improvement and positive cash flow generation being key metrics for investors in the cannabis industry. Traders will be watching for continued operational efficiency gains and the company's strategy amidst ongoing industry consolidation and potential regulatory changes.
At the time of this announcement, CRLBF was trading at $0.98 on OTC in the Trade & Services sector, with a market capitalization of approximately $433.8M. The 52-week trading range was $0.43 to $2.30. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.